NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
March 4, 2008 • Volume 5 / Number 5 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
ALTTO Trial Seeks to Define Best Therapy for HER2 Breast Cancer

Cancer Research Highlights
Cancer Risk Persists After Ending Hormone Therapy

Hormone Therapy Interferes with Breast Cancer Detection

Study Confirms Clot, Mortality Risks with Anemia Drugs

Sentinel Node Dissection Safe in Early Vulvar Cancer Treatment

Smoking Threatens Pregnant Women in Developing Countries

Director's Update
Keeping Recent Mortality Figures in Perspective

Funding Opportunities

Special Report
Tiny Nodules, Big Dilemma

FDA Update
Bevacizumab Approved for Metastatic Breast Cancer

Featured Clinical Trial
Continuing Bevacizumab Therapy for Metastatic Colorectal Cancer

Notes
NIH Director to Testify Before Appropriations Subcommittee

BSA Meeting Held

Special Issue on Childhood Cancers

Cancer Center Profile
Lombardi Comprehensive Cancer Center

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Notes

Special Issue on Childhood Cancers

Don't miss our March 18 special issue of the NCI Cancer Bulletin, which will focus on childhood cancers. The issue will feature articles about NCI's intramural and extramural research efforts in pediatric cancers and will provide a list of resources for additional information.

NCI Cancer Bulletin special issues are some of the most popular among our readership. Past special issues have focused on cancer survivorship, cancer prevention, and NCI-Frederick.

NIH Director to Testify Before Appropriations Subcommittee
NIH Director Dr. Elias Zerhouni is scheduled to testify before the House Appropriations Subcommittee on Labor-HHS-Education on March 5. Appearing with Dr. Zerhouni will be the heads of the Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Administration, and the Agency for Healthcare Research and Quality. The focus of the hearing will be on programmatic outcomes and the linkages between each agency's programs.

BSA Meeting Held
NCI's Board of Scientific Advisors (BSA) met March 3-4 on the NIH campus in Bethesda, MD. The public portions of the meeting can be viewed at http://videocast.nih.gov/PastEvents.asp.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov